Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study

OBJECTIVE: Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycystic ovary syndrome (PCOS) is characterized by androgen excess and irregular menses; androgens are drivers of increased metabolic risk in women with PCOS. Combined oral contraceptive pills (COCPs) are...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumarendran, Balachandran, O'Reilly, Michael W., Subramanian, Anuradhaa, Šumilo, Dana, Toulis, Konstantinos, Gokhale, Krishna M., Wijeratne, Chandrika N., Coomarasamy, Arri, Tahrani, Abd A., Azoulay, Laurent, Arlt, Wiebke, Nirantharakumar, Krishnarajah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669537/
https://www.ncbi.nlm.nih.gov/pubmed/34649997
http://dx.doi.org/10.2337/dc21-0437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669537/
https://www.ncbi.nlm.nih.gov/pubmed/34649997
http://dx.doi.org/10.2337/dc21-0437

Ejemplares similares